Medical Device News Magazine

hear.com Unveils Next-Gen Addition to Horizon AX Hearing Aid Line

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

hear.com, the world’s largest online provider of expert, medical-grade hearing care, today announced the launch of its new hearing aid line, the Horizon AX, enhancing its already robust product portfolio. In support of hear.com’s mission to bring high-quality hearing care to anyone, anywhere, the new family of hearing aids are for those seeking an affordable, easy-to-use solution that provides the most advanced sound experience possible.

Nearly 2.5 billion people are projected to have some degree of hearing loss globally by 2050, yet there is a gap in hearing care driven by both limited affordability and access to quality devices, along with the perceived stigma of hearing aids. When combined with hear.com’s two-tier case management approach, the new Horizon AX line goes a long way toward addressing the root causes of subpar hearing care and acceptability. The hear.com Horizon AX hearing aid line boasts an elite, revolutionary sound experience not found in any other hearing devices on the market today. The stylish design offers discrete placement and provides users with excellent speech understanding, built-in situation detection technology, and bespoke features specifically for the more active user, including:

  • Speech Focus Mode provides an extra boost of crystal-clear speech comprehension by identifying and suppressing background noise in real time – allowing the user to focus on one-on-one conversations even in noisy environments like restaurants, sporting events, conferences, etc.
  • Panorama Mode boosts sound clarity in a 360-degree radius around the user, ensuring clear and realistic comprehension from every direction.
  • Relax Mode mutes microphones at the touch of a button and emits serene, stress-relieving ocean sounds.

Horizon AX products also make it possible to clear speech understanding, combining the most innovative technology with the experience of over three million customer consultations. Using two separate processors, this state-of-the-art technology significantly increases the contrast between speech and background noise, making speech more easily understandable and accentuating frequencies at the user’s fingertips.

“The best hearing aid we’ve ever sold,” hear.com’s Horizon AX seamlessly connects users to the world. All devices come with Bluetooth connection, rechargeable batteries, and direct integration with both Apple iPhone and Android products. The Horizon smartphone app for simple, discreet hearing care management allows users to access music, telephone calls, podcasts and even TV with the Streamline TV feature.

Featuring three unique styles – the Style, Go and Mini – the Horizon AX line is designed to offer cutting-edge technology without compromising style or comfort. The line is available in multiple colors with a sleek behind-the-ear style and will be available as  in-the-canal hearing aids later this year.

The hear.com Horizon AX is available to be fit today either via a hand-selected hear.com partner audiologist or the company’s Tele-Audiology option. hear.com’s Clinic-in-a-Box™ Tele-Audiology journey delivers a package including a tablet, hearing aids, and all diagnostic equipment needed to conduct a high-quality medical hearing evaluation and fitting of hearing devices, right to your doorstep, and is proven to deliver superior outcomes versus in-clinic fittings.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”